C B Cairns1, J T Niemann. 1. Harbor-UCLA Medical Center, The Department of Emergency Medicine, Torrance, CA 90509, USA.
Abstract
STUDY PURPOSE: To assess the hemodynamic response to repeated doses of epinephrine (EPI) in an animal model of prolonged cardiac arrest and CPR. DESIGN: Basic laboratory investigation. Fourteen canines were subjected to electrically induced ventricular fibrillation (VF) followed by 7.5 min of VF without CPR. INTERVENTIONS: After 7.5 min of VF, manual closed-chest CPR (80-100 compressions per minute, compression to ventilation ratio 8:1) was initiated. Countershocks were performed, recommended advanced cardiac life support drugs were given, and CPR was continued until restoration of spontaneous circulation (ROSC) or for 20 min. Epinephrine, 1 mg (approximately 0.04 mg kg(-1)), was administered when indicated and at recommended time intervals. METHODS: Aortic and right atrial pressures were measured with micromanometer catheters before and after EPI, and CPR coronary perfusion pressure (CPP) was calculated (CPR diastolic aortic to right atrial pressure difference). Survival was defined as maintenance of ROSC for 30 min. RESULTS: Countershocks after 7.5 min resulted in asystole in ten animals and persistant VF in four. In those animals successfully resuscitated (n = 3), the change in CPP was 21 +/- 11 mm Hg after the first dose of EPI. Only one animal required a second dose of EPI. The majority of the study group (n = 11) could not be resuscitated. The increase in CPP after EPI averaged only 3 +/- 2 mm Hg and subsequent doses produced no significant effect on CPP (2 +/- 4 mm Hg). CONCLUSIONS: The hemodynamic response to the first dose of EPI determines if the critical CPP needed for ROSC and survival will occur. Repeat doses of EPI do not appear to improve CPP to a degree to affect clinically meaningful measures of outcome, i.e., successful countershock and survival.
STUDY PURPOSE: To assess the hemodynamic response to repeated doses of epinephrine (EPI) in an animal model of prolonged cardiac arrest and CPR. DESIGN: Basic laboratory investigation. Fourteen canines were subjected to electrically induced ventricular fibrillation (VF) followed by 7.5 min of VF without CPR. INTERVENTIONS: After 7.5 min of VF, manual closed-chest CPR (80-100 compressions per minute, compression to ventilation ratio 8:1) was initiated. Countershocks were performed, recommended advanced cardiac life support drugs were given, and CPR was continued until restoration of spontaneous circulation (ROSC) or for 20 min. Epinephrine, 1 mg (approximately 0.04 mg kg(-1)), was administered when indicated and at recommended time intervals. METHODS: Aortic and right atrial pressures were measured with micromanometer catheters before and after EPI, and CPR coronary perfusion pressure (CPP) was calculated (CPR diastolic aortic to right atrial pressure difference). Survival was defined as maintenance of ROSC for 30 min. RESULTS: Countershocks after 7.5 min resulted in asystole in ten animals and persistant VF in four. In those animals successfully resuscitated (n = 3), the change in CPP was 21 +/- 11 mm Hg after the first dose of EPI. Only one animal required a second dose of EPI. The majority of the study group (n = 11) could not be resuscitated. The increase in CPP after EPI averaged only 3 +/- 2 mm Hg and subsequent doses produced no significant effect on CPP (2 +/- 4 mm Hg). CONCLUSIONS: The hemodynamic response to the first dose of EPI determines if the critical CPP needed for ROSC and survival will occur. Repeat doses of EPI do not appear to improve CPP to a degree to affect clinically meaningful measures of outcome, i.e., successful countershock and survival.
Authors: Manoel Ângelo Gomes Palácio; Edison Ferreira de Paiva; Luciano Cesar Pontes de Azevedo; Ari Timerman Journal: Arq Bras Cardiol Date: 2013-11-01 Impact factor: 2.000
Authors: Scott T Youngquist; Atman Shah; Christian McClung; Joseph L Thomas; John P Rosborough; James T Niemann Journal: Resuscitation Date: 2010-11-03 Impact factor: 5.262
Authors: Henrik Wagner; Michael Götberg; Bjarne Madsen Hardig; Malin Rundgren; Jonas Carlson; Matthias Götberg; David Zughaft; David Erlinge; Göran K Olivecrona Journal: BMC Cardiovasc Disord Date: 2014-12-20 Impact factor: 2.298
Authors: Yong Hun Jung; Najmiddin Mamadjonov; Hyoung Youn Lee; Kyung Woon Jeung; Byung Kook Lee; Chun Song Youn; Tag Heo; Yong Il Min Journal: J Am Heart Assoc Date: 2020-02-19 Impact factor: 5.501
Authors: Yong Hun Jung; Dong Hyun Ryu; Kyung Woon Jeung; Joo-Young Na; Dong Hun Lee; Byung Kook Lee; Tag Heo; Yong Il Min Journal: Clin Exp Emerg Med Date: 2019-05-07
Authors: Mohammed A Al-Mulhim; Mohammed S Alshahrani; Laila Perlas Asonto; Ahmad Abdulhady; Talal M Almutairi; Mariam Hajji; Mohammed A Alrubaish; Khalid N Almulhim; Mariam H Al-Sulaiman; Layla B Al-Qahtani Journal: J Int Med Res Date: 2019-07-16 Impact factor: 1.671
Authors: Martha F Kienzle; Ryan W Morgan; Jennifer A Faerber; Kathryn Graham; Hannah Katcoff; William P Landis; Alexis A Topjian; Todd J Kilbaugh; Vinay M Nadkarni; Robert A Berg; Robert M Sutton Journal: Am J Respir Crit Care Med Date: 2021-10-15 Impact factor: 30.528
Authors: Constantine D Mavroudis; Tiffany S Ko; Ryan W Morgan; Lindsay E Volk; William P Landis; Benjamin Smood; Rui Xiao; Marco Hefti; Timothy W Boorady; Alexandra Marquez; Michael Karlsson; Daniel J Licht; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh Journal: Crit Care Date: 2020-09-29 Impact factor: 9.097